clopidogrel 1a pharma
acino pharma gmbh - clopidogrel - peripheral vascular diseases - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in:patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.patients suffering from acute coronary syndrome:- non st segment elevation acute coronary syndrome (unstable angina or non q wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa).- st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy.for further information please refer to section 5.1.
metohexal 50 tablet
imeks pharma sdn. bhd. - metoprolol tartrate -
metohexal 100 tablet
imeks pharma sdn. bhd. - metoprolol tartrate -
ranitic tablet 150mg
imeks pharma sdn. bhd. - ranitidine hydrochloride -
tramadolor 50 capsule
imeks pharma sdn. bhd. - tramadol hydrochloride -
enahexal 5mg tablet
idaman pharma sdn. bhd. - enalapril maleate -
enahexal 20mg tablet
idaman pharma sdn. bhd. - enalapril maleate -
amiohexal 200
imeks pharma sdn. bhd. - amiodarone hydrochloride -
diclac retard 100mg tab
imeks pharma sdn. bhd. - diclofenac sodium -
diclac® 150 id modified-release tablet
imeks pharma sdn. bhd. - diclofenac sodium -